От тела к мозгу. Как нарушения метаболизма становятся причиной депрессии, биполярного расстройства, СДВГ, ПТСР и других заболеваний - Кристофер М. Палмер
10. M. É. Czeisler, R. I. Lane, E. Petrosky, et al. “Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic – United States, June 24–30, 2020.” MMWR Morb Mortal Wkly Rep 69 (2020): 1049–1057. doi: 10.15585/mmwr.mm6932a1external icon.
11. The Lancet Global Health. “Mental Health Matters.” Lancet Glob Health 8(11) (November 2020): e1352.
12. Global Burden of Disease Collaborative Network. “Global Burden of Disease Study 2015 (GBD 2015) Life Expectancy, All-Cause and Cause-Specific Mortality 1980–2015.” Seattle, United States: Institute for Health Metrics and Evaluation (IHME), 2016.
13. US Department of Housing and Urban Development. “The 2010 Annual Homeless Assessment Report to Congress.” US Department of Housing and Urban Development. https://www.huduser.gov/portal/sites/ default/files/pdf/2010HomelessAssessmentReport.pdf.
14. Doris J. James and Lauren E. Glaze. “Mental Health Problems of Prison and Jail Inmates.” Bureau of Justice Statistics, US Dept. of Justice (September 2006). https://bjs.ojp.gov/library/publications/mental-health – problems-prison-and-jail-inmates.
15. National Institute of Mental Health. “Major Depression.” National Institute of Mental Health, US Dept.of Health and Human Services. https://www.nimh.nih.gov/health/statistics/major-depression#:~:text =all%20U.S.%20adults.-,Treatment%20of%20Major%20Depressive%20Episode%20Among%20Adults, treatment%20in%20the%20past%20year. Retrieved 2/18/2022.
16. L. L. Judd, H. S. Akiskal, J. D. Maser, et al. “A Prospective 12-Year Study of Subsyndromal and Syndromal Depressive Symptoms in Unipolar Major Depressive Disorders.” Arch Gen Psychiatry. 55(8) (1998): 694–700. doi: 10.1001/archpsyc.55.8.694.
17. Sidney Zisook, Gary R. Johnson, Ilanit Tal, Paul Hicks, Peijun Chen, Lori Davis, Michael Thase, Yinjun Zhao, Julia Vertrees, and Somaia Mohamed. “General Predictors and Moderators of Depression Remission: A VAST-D Report.” Am. J Psychiatry 176(5) (May 1, 2019): 348–357. doi: 10.1176/appi.ajp.2018.18091079.
18. Diego Novick, Josep Maria Haro, David Suarez, Eduard Vieta, and Dieter Naber. “Recovery in the Outpatient Setting: 36-Month Results from the Schizophrenia Outpatients Health Outcomes (SOHO) Study.” Schizophr Res 108(1) (2009): 223–230. doi: 10.1016/j.schres.2008.11.007.
19. Adam Rogers. “Star Neuroscientist Tom Insel Leaves the Google-Spawned Verily for… a Startup?” Wired. May 11, 2017. https://www.wired.com/2017/05/star-neuroscientist-tom-insel-leaves-google-spawned-verily-startup/#:~:text=%E2%80%9CI%20spent%2013%20years%20at,we%20moved%20the%20needle%20in.
Глава 2
1. G. L. Engel. “The Need for a New Medical Model: A Challenge for Biomedicine.” Science 196(4286) (1977): 129–136. doi: 10.1126/science.847460.
2. M. B. Howren, D. M. Lamkin, and J. Suls. “Associations of Depression with C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis.” Psychosom Med. 71(2) (February 2009): 171–186. doi: 10.1097/ PSY.0b013e3181907c1b.
3. E. Setiawan, S. Attwells, A. A. Wilson, R. Mizrahi, P. M. Rusjan, L. Miler, C. Xu, S. Sharma, S. Kish, S. Houle, and J. H. Meyer. “Association of Translocator Protein Total Distribution Volume with Duration of Untreated Major Depressive Disorder: A Cross-Sectional Study.” Lancet Psychiatry 5(4) (April 2018): 339–347. doi: 10.1016/S2215-0366(18)30048-8.
4. C. Zhuo, G. Li, X. Lin, et al. “The Rise and Fall of MRI Studies in Major Depressive Disorder.” Transl Psychiatry 9(335) (2019). doi.org/10.1038/s41398-019-0680-6.
5. A. L. Komaroff. “The Microbiome and Risk for Obesity and Diabetes.” JAMA 317(4) (2017): 355–356.doi: 10.1001/jama.2016.20099; K. E. Bouter, D. H. van Raalte, A. K. Groen, et al. “Role of the Gut Microbiome in the Pathogenesis of Obesity and Obesity-Related Metabolic Dysfunction.” Gastroenterology 152(7) (May 2017): 1671–1678. doi: 10.1053/j.gastro.2016.12.048; E. A. Mayer, K. Tillisch, and A. Gupta. “Gut/ Brain Axis and the Microbiota.” J Clin Invest 125(3) (2015): 926–938. doi: 10.1172/JCI76304.
6. J. A. Foster and K. A. McVey Neufeld. “Gut-Brain Axis: How the Microbiome Influences Anxiety and Depression.” Trends Neurosci 36(5) (May 2013): 305–312. doi: 10.1016/j.tins.2013.01.005.
Глава 3
1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. 4th ed. Arlington, VA: American Psychiatric Association, 2000: 356.
2. E. Corruble, B. Falissard, and P. Gorwood. “Is DSM-IV Bereavement Exclusion for Major Depression Relevant to Treatment Response? A Case-Control, Prospective Study.” J Clin Psychiatry 72(7) (July 2011): 898–902. doi: 10.4088/JCP.09m05681blu.
3. Alan F. Schatzberg. “Scientific Issues Relevant to Improving the Diagnosis, Risk Assessment, and Treatment of Major Depression.” Am J Psychiatry 176(5) (2019): 342–47. doi: 10.1176/appi.ajp.2019. 19030273.
4. M. K. Jha, A. Minhajuddin, C. South, A. J. Rush, and M. H. Trivedi. “Irritability and Its Clinical Utility in Major Depressive Disorder: Prediction of Individual-Level Acute-Phase Outcomes Using Early Changes in Irritability and Depression Severity.” Am J Psychiatry 176(5) (May 1, 2019): 358–366. doi: 10.1176/appi.ajp.2018.18030355. Epub Mar 29, 2019. PMID: 30922100.
5. Maurice M. Ohayon and Alan F. Schatzberg. “Chronic Pain and Major Depressive Disorder in the General Population.” J Psychiatr Res 44(7) (2010): 454–61. doi: 10.1016/j.jpsychires.2009.10.013.
6. R. C. Kessler, W. T. Chiu, O. Demler, and E. E. Walters. “Prevalence, Severity, and Comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication.” Arch Gen Psychiatry 62(6) (2005): 617–627. doi: 10.1001/archpsyc.62.6.617.
7. R. C. Kessler, P. Berglund, O. Demler, et al. “The Epidemiology of Major Depressive Disorder: Results from the National Comorbidity Survey Replication (NCS-R).” JAMA 289 (2003): 3095–3105. doi: 10.1001/ jama.289.23.3095; B. W. Penninx, D. S. Pine, E. A. Holmes, and A. Reif. “Anxiety Disorders.” Lancet 397(10277) (2021): 914–927.
8. M. Olfson, S. C. Marcus, and J. G. Wan. “Treatment Patterns for Schizoaffective Disorder and Schizophrenia Among Medicaid Patients.” Psychiatr Serv 60 (2009): 210–216. doi: 10.1176/ps.2009.60.2.210.
9. Seth Himelhoch, Eric Slade, Julie Kreyenbuhl, Deborah Medoff, Clayton Brown, and Lisa Dixon. “Antidepressant Prescribing Patterns Among VA Patients with Schizophrenia.” Schizophr Res 136(1) (2012): 32–35. doi: 10.1016/j.schres.2012.01.008.
10. P. D. Harvey, R. K. Heaton, W. T. Carpenter Jr., M. F. Green, J. M. Gold, and M. Schoenbaum. “Functional Impairment in People with Schizophrenia: Focus on Employability and Eligibility for Disability Compensation.” Schizophr Res 140(1–3) (2012): 1–8. doi: 10.1016/j.schres.2012.03.025.
11. L. L. Judd, H. S. Akiskal, P. J. Schettler, et al. “The Long-Term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder.” Arch Gen Psychiatry 59(6) (June 2002): 530–537. doi: 10.1001/archpsyc.59.6.530.
12. “Biomarkers Outperform Symptoms in Parsing Psychosis Subgroups.” National Institutes of Health. December 8, 2015. htps://www.nih.gov/news-events/news-releases/biomarkers-outperform-symptoms-parsing – psychosis-subgroups.
13. Maurice M. Ohayon and Alan F. Schatzberg. “Prevalence of Depressive Episodes with Psychotic Features in the General Population.” Am J Psychiatry 159(11) (2002): 1855–1861. doi: 10.1176/appi.ajp.159.11.1855.
14. B. Bandelow and S. Michaelis. “Epidemiology of Anxiety Disorders in the 21st Century.” Dialogues Clin Neurosci 17(3) (2015): 327–335. doi: 10.31887/DCNS.2015.17.3/bbandelow.
15. O. Plana-Ripoll, C. B. Pedersen, Y. Holtz, et al. “Exploring Comorbidity Within Mental Disorders Among a Danish National Population.” JAMA Psychiatry 76(3) (2019): 259–270. doi: 10.1001/ jamapsychiatry.2018.3658.
16. R. C. Kessler, W. T. Chiu, O. Demler, and E. E. Walters. “Prevalence, Severity, and Comorbidity of 12-Month
